The present invention relates to salts of organic acid, in particular salt of nateglinide, combined preparations comprising one or more salts of nateglinide and, optionally, one or more additional ingredients and the use thereof in pharmaceutical compositions for preventing or treating diabetes, cardiovascular disease, or conditions associated therewith.

 
Web www.patentalert.com

< NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES

> Use of RR/SR-ractopamine

> NOVEL GENES AND THEIR USE IN THE MODULATION OF OBESITY, DIABETES AND ENERGY IMBALANCE

~ 00523